• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米内利德:一种新型治疗药物,可促进体内非小细胞肺癌细胞凋亡。

Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.

机构信息

Division of Basic and Translational Research, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America.

出版信息

PLoS One. 2013 Oct 15;8(10):e77411. doi: 10.1371/journal.pone.0077411. eCollection 2013.

DOI:10.1371/journal.pone.0077411
PMID:24143232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3797124/
Abstract

BACKGROUND

Minnelide, a pro-drug of triptolide, has recently emerged as a potent anticancer agent. The precise mechanisms of its cytotoxic effects remain unclear.

METHODS

Cell viability was studied using CCK8 assay. Cell proliferation was measured real-time on cultured cells using Electric Cell Substrate Impedence Sensing (ECIS). Apoptosis was assayed by Caspase activity on cultured lung cancer cells and TUNEL staining on tissue sections. Expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA, APAF-1) was estimated by qRTPCR. Effect of Minnelide on proliferative cells in the tissue was estimated by Ki-67 staining of animal tissue sections.

RESULTS

In this study, we investigated in vitro and in vivo antitumor effects of triptolide/Minnelide in non-small cell lung carcinoma (NSCLC). Triptolide/Minnelide exhibited anti-proliferative effects and induced apoptosis in NSCLC cell lines and NSCLC mouse models. Triptolide/Minnelide significantly down-regulated the expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA) and up-regulated pro-apoptotic APAF-1 gene, in part, via attenuating the NF-κB signaling activity.

CONCLUSION

In conclusion, our results provide supporting mechanistic evidence for Minnelide as a potential in NSCLC.

摘要

背景

米内利德是雷公藤红素的前体药物,最近已成为一种有效的抗癌药物。其细胞毒性作用的确切机制尚不清楚。

方法

使用 CCK8 法研究细胞活力。使用电动细胞基质阻抗感应(ECIS)在培养的细胞上实时测量细胞增殖。通过 Caspase 活性测定和组织切片 TUNEL 染色检测培养的肺癌细胞凋亡。通过 qRT-PCR 估计抗凋亡和抗凋亡基因(HSP70、BIRC5、BIRC4、BIRC2、UACA、APAF-1)的表达。通过 Ki-67 染色评估米内利德对动物组织切片中增殖细胞的影响。

结果

在这项研究中,我们研究了雷公藤红素/米内利德在非小细胞肺癌(NSCLC)中的体外和体内抗肿瘤作用。雷公藤红素/米内利德在 NSCLC 细胞系和 NSCLC 小鼠模型中表现出抗增殖作用,并诱导细胞凋亡。雷公藤红素/米内利德显著下调了抗凋亡基因(HSP70、BIRC5、BIRC4、BIRC2、UACA)的表达,并上调了促凋亡基因 APAF-1 的表达,部分通过抑制 NF-κB 信号活性。

结论

总之,我们的结果为米内利德作为 NSCLC 的潜在治疗药物提供了支持性的机制证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/d13e38e41886/pone.0077411.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/c00d4f6b5c8d/pone.0077411.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/ef8acf0b9aff/pone.0077411.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/654718fc8e42/pone.0077411.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/6dcd2432269a/pone.0077411.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/76c0522cf8ce/pone.0077411.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/d13e38e41886/pone.0077411.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/c00d4f6b5c8d/pone.0077411.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/ef8acf0b9aff/pone.0077411.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/654718fc8e42/pone.0077411.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/6dcd2432269a/pone.0077411.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/76c0522cf8ce/pone.0077411.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480b/3797124/d13e38e41886/pone.0077411.g006.jpg

相似文献

1
Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.米内利德:一种新型治疗药物,可促进体内非小细胞肺癌细胞凋亡。
PLoS One. 2013 Oct 15;8(10):e77411. doi: 10.1371/journal.pone.0077411. eCollection 2013.
2
Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.米内立德对Sp1的下调导致热休克蛋白70减少以及胃癌肿瘤负荷降低。
PLoS One. 2017 Feb 13;12(2):e0171827. doi: 10.1371/journal.pone.0171827. eCollection 2017.
3
Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.水溶性前体药物米内立德对上皮性卵巢癌的抑制作用。
Gynecol Oncol. 2014 Nov;135(2):318-24. doi: 10.1016/j.ygyno.2014.08.031. Epub 2014 Aug 27.
4
Minnelide reduces tumor burden in preclinical models of osteosarcoma.米内利德可减少骨肉瘤临床前模型中的肿瘤负担。
Cancer Lett. 2013 Jul 28;335(2):412-20. doi: 10.1016/j.canlet.2013.02.050. Epub 2013 Mar 14.
5
Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.米内利德通过降低雄激素受体全长及剪接变体的表达来抑制雄激素依赖性、去势抵抗性前列腺癌的生长。
Prostate. 2017 May;77(6):584-596. doi: 10.1002/pros.23298. Epub 2017 Feb 1.
6
Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer.米内利德通过下调胰腺癌中的DNA修复途径克服奥沙利铂耐药性。
J Gastrointest Surg. 2016 Jan;20(1):13-23; discussion 23-4. doi: 10.1007/s11605-015-3000-3. Epub 2015 Oct 26.
7
Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.米内利德/雷公藤甲素通过在非小细胞肺癌中以p53依赖的方式调节SIRT3来损害线粒体功能。
PLoS One. 2016 Aug 8;11(8):e0160783. doi: 10.1371/journal.pone.0160783. eCollection 2016.
8
Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.雷公藤甲素通过抑制E2F的转录激活来消除结肠癌的生长并诱导细胞周期停滞。
Lab Invest. 2015 Jun;95(6):648-659. doi: 10.1038/labinvest.2015.46. Epub 2015 Apr 20.
9
Minnelide exhibits antileukemic activity by targeting the Ars2/miR-190a-3p axis.米内利德通过靶向 Ars2/miR-190a-3p 轴发挥抗白血病活性。
Phytomedicine. 2024 Jul 25;130:155724. doi: 10.1016/j.phymed.2024.155724. Epub 2024 May 11.
10
Sorafenib and triptolide as combination therapy for hepatocellular carcinoma.索拉非尼联合雷公藤内酯醇治疗肝细胞癌。
Surgery. 2014 Aug;156(2):270-9. doi: 10.1016/j.surg.2014.04.055. Epub 2014 Jun 19.

引用本文的文献

1
Pan-cell death-related signature reveals tumor immune microenvironment and optimizes personalized therapy alternations in lung adenocarcinoma.Pan-cell 死亡相关特征揭示肺腺癌肿瘤免疫微环境并优化个体化治疗方案。
Sci Rep. 2024 Jul 8;14(1):15682. doi: 10.1038/s41598-024-66662-1.
2
Minnelide suppresses GVHD and enhances survival while maintaining GVT responses.米那利德抑制移植物抗宿主病并提高存活率,同时保持移植物抗肿瘤反应。
JCI Insight. 2024 Apr 11;9(9):e165936. doi: 10.1172/jci.insight.165936.
3
Genetic diversities in wild and cultivated populations of the two closely-related medical plants species, Tripterygium Wilfordii and T. Hypoglaucum (Celastraceae).

本文引用的文献

1
Minnelide reduces tumor burden in preclinical models of osteosarcoma.米内利德可减少骨肉瘤临床前模型中的肿瘤负担。
Cancer Lett. 2013 Jul 28;335(2):412-20. doi: 10.1016/j.canlet.2013.02.050. Epub 2013 Mar 14.
2
Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity.雷公藤红素介导的神经母细胞瘤细胞死亡是通过细胞凋亡和自噬途径发生的,并导致核因子-κB 活性的抑制。
Am J Surg. 2013 Apr;205(4):387-96. doi: 10.1016/j.amjsurg.2013.01.008. Epub 2013 Feb 19.
3
Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.
两种密切相关的药用植物物种(卫矛科雷公藤属和雷公藤属)的野生和栽培种群的遗传多样性。
BMC Plant Biol. 2024 Mar 16;24(1):195. doi: 10.1186/s12870-024-04826-x.
4
HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances.热休克蛋白 70 家族与癌症:信号机制与治疗进展。
Biomolecules. 2023 Mar 27;13(4):601. doi: 10.3390/biom13040601.
5
Reciprocal Regulation of Hippo and WBP2 Signalling-Implications in Cancer Therapy.Hippo 和 WBP2 信号的相互调节——在癌症治疗中的意义。
Cells. 2021 Nov 11;10(11):3130. doi: 10.3390/cells10113130.
6
The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors.分子肿瘤图谱对靶向髓系白血病和EGFR/CD44阳性实体瘤的设计策略的影响。
Beilstein J Nanotechnol. 2021 Apr 29;12:375-401. doi: 10.3762/bjnano.12.31. eCollection 2021.
7
Heat Shock Proteins in Lymphoma Immunotherapy.热休克蛋白在淋巴瘤免疫治疗中的作用。
Front Immunol. 2021 Mar 18;12:660085. doi: 10.3389/fimmu.2021.660085. eCollection 2021.
8
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.从植物源萜类内酯骨架中开发潜在的抗肿瘤药物。
J Med Chem. 2020 Dec 24;63(24):15410-15448. doi: 10.1021/acs.jmedchem.0c01449. Epub 2020 Dec 8.
9
Triptolide-induced apoptosis in non-small cell lung cancer via a novel miR204-5p/Caveolin-1/Akt-mediated pathway.雷公藤甲素通过一种新的miR204 - 5p/小窝蛋白-1/Akt介导的途径诱导非小细胞肺癌细胞凋亡。
Oncotarget. 2020 Jul 14;11(28):2793-2806. doi: 10.18632/oncotarget.27672.
10
HSP70 Multi-Functionality in Cancer.热休克蛋白 70 家族在癌症中的多功能性。
Cells. 2020 Mar 2;9(3):587. doi: 10.3390/cells9030587.
细胞外 PAR-4 介导的癌症细胞凋亡抵抗的新机制。
Cancer Res. 2013 Jan 15;73(2):1011-9. doi: 10.1158/0008-5472.CAN-12-3212. Epub 2012 Nov 30.
4
Phosphorylation of ribosomal protein S3 and antiapoptotic TRAF2 protein mediates radioresistance in non-small cell lung cancer cells.核糖体蛋白 S3 的磷酸化和抗凋亡 TRAF2 蛋白介导非小细胞肺癌细胞的放射抵抗。
J Biol Chem. 2013 Feb 1;288(5):2965-75. doi: 10.1074/jbc.M112.385989. Epub 2012 Nov 27.
5
A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer. Minnelide 作为一种治疗胰腺癌的治疗剂的临床前评估。
Sci Transl Med. 2012 Oct 17;4(156):156ra139. doi: 10.1126/scitranslmed.3004334.
6
Nucling, a novel protein associated with NF-κB, regulates endotoxin-induced apoptosis in vivo.核因子 κB 相关蛋白 Nucling 调控内毒素诱导的细胞凋亡。
J Biochem. 2013 Jan;153(1):93-101. doi: 10.1093/jb/mvs119. Epub 2012 Oct 15.
7
The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.凋亡抑制蛋白(IAP)是信号通路的关键调节因子,也是抗癌治疗的靶点。
Exp Oncol. 2012 Oct;34(3):200-11.
8
Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies.Survivin 在非小细胞肺癌中的表达与患者生存的关系:一项荟萃分析。
Mol Biol Rep. 2013 Feb;40(2):917-24. doi: 10.1007/s11033-012-2132-8. Epub 2012 Oct 13.
9
Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.同时阻断 NF-κB 和 Akt 通路可增强顺铂在体内的抗肿瘤活性。
Anticancer Drugs. 2012 Nov;23(10):1039-46. doi: 10.1097/CAD.0b013e32835679b8.
10
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.AXL 激酶的激活导致肺癌对 EGFR 靶向治疗产生耐药性。
Nat Genet. 2012 Jul 1;44(8):852-60. doi: 10.1038/ng.2330.